Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
25.71
+1.76 (7.35%)
Apr 7, 2026, 4:00 PM EDT - Market closed
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $425.94 million as of April 8, 2026. Its market cap has increased by 538.74% in one year.
Market Cap
425.94M
Enterprise Value
300.19M
1-Year Change
538.74%
Ranking
Category
Stock Price
$25.71
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has increased from $346.92M to $425.94M, an increase of 22.78%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 396.79M | 302.54% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 423.99M |
| Vanda Pharmaceuticals | 411.98M |
| XOMA Royalty | 402.16M |
| Ginkgo Bioworks Holdings | 399.88M |
| Century Therapeutics | 393.59M |
| Armata Pharmaceuticals | 386.48M |
| Neumora Therapeutics | 385.93M |
| Enanta Pharmaceuticals | 384.51M |